EFFECTS OF CHANGES IN CONDITIONING REGIMEN AND SUPPORTIVE CARE ON OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT)

被引：0
|
作者：
Abello, V [1 ]
Rosales, C. [1 ]
Pedraza, E. [1 ]
Linares, A. [1 ]
Esguerra, H. [1 ]
Rosales, M. [1 ]
Figueroa, J. [1 ]
机构：
[1] Clin Marly, Bogota, Colombia
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
200
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [1] Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)
    Siddhartha Ganguly
    Manik Amin
    Clint Divine
    Omar S. Aljitawi
    Sunil Abhyankar
    Joseph P. McGuirk
    Annals of Hematology, 2013, 92 : 549 - 550
  • [2] Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)
    Ganguly, Siddhartha
    Amin, Manik
    Divine, Clint
    Aljitawi, Omar S.
    Abhyankar, Sunil
    McGuirk, Joseph P.
    ANNALS OF HEMATOLOGY, 2013, 92 (04) : 549 - 550
  • [3] Reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) for patients with acute myeloid leukemia (AML): A donor versus no donor comparison
    Mohty, M
    de Lavallade, H
    Ladaique, P
    Faucher, C
    Vey, N
    Coso, D
    Stoppa, AM
    Gastaut, JA
    Blaise, D
    BLOOD, 2005, 106 (11) : 439B - 439B
  • [4] Allogeneic Stem Cell Transplantation (allo-SCT) for Secondary Acute Myeloid Leukemia (AML) Following Breast Carcinoma.
    Ayari, Sameh
    Mohty, Mohamad
    Bilger, Karin
    Guillerm, Gaelle
    Guyotat, Denis
    Michallet, Mauricette
    Ifrah, Norbert
    Chevallier, Patrice
    BLOOD, 2009, 114 (22) : 1281 - 1282
  • [5] Cure by chemotherapy without allogeneic stem cell transplantation (ALLO-SCT) in pediatric relapsed acute myeloid leukemia (AML)?
    Kaspers, G. J. L.
    Goemans, B. F.
    Korbijn, C.
    Tamminga, R. Y.
    Hahlen, K.
    ANNALS OF HEMATOLOGY, 2008, 87 : S3 - S3
  • [6] Sequential Regimen of Clofarabine, Cytarabine and Reduced Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in Primary Treatment Failure
    Mohty, Mohamad
    Malard, Florent
    Blaise, Didier
    Milpied, Noel
    Socie, Gerard
    Huynh, Anne
    Oumedaly, Reman
    Yakoub-Agha, Ibrahim
    Furst, Sabine
    Guillaume, Thierry
    Tabrizi, Reza
    Delaunay, Jacques
    Moreau, Philippe
    Labopin, Myriam
    Chevallier, Patrice
    BLOOD, 2014, 124 (21)
  • [7] Sequential Regimen of Clofarabine, Cytarabine and Reduced Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in Primary Treatment Failure
    Mohty, M.
    Malard, F.
    Blaise, D.
    Milpied, N.
    Socie, G.
    Huynh, A.
    Reman, O.
    Yakoub-Agha, I.
    Furst, S.
    Guillaume, T.
    Tabrizi, R.
    Delaunay, J.
    Moreau, P.
    Labopin, M.
    Chevallier, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S15 - S15
  • [8] The role of reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML): A donor versus no donor comparison.
    Mohty, M
    de Lavallade, H
    Faucher, C
    Vey, N
    Gastaut, JA
    Blaise, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 570S - 570S
  • [9] The role of reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (ALLO-SCT) in patients with acute myeloid leukemia (AML): A donor versus no donor comparison
    De Lavallade, H
    Mohty, M
    Faucher, C
    Vey, N
    Coso, D
    Stoppa, AM
    Gastaut, JA
    Ladaique, P
    Chabannon, C
    Blaise, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 3 - 3
  • [10] ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN THE ELDERLY PATIENTS (AGE > 65 YEARS) WITH ACUTE MYELOID LEUKEMIA (AML) IS SAFE AND EFFECTIVE
    Jagadeesh, D.
    Cerny, J.
    Ramanathan, M.
    Raffel, G. D.
    Petrillo-Deluca, L.
    Tarrasky, N.
    Krumpe, L. M.
    Bednarik, J.
    Barton, B. A.
    Walsh, W., V
    Nath, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S292 - S292
12345